Warden Kathy J — SEC Form 4 filings
SEC reporting owner CIK 1559112. 13 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-02-16 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 4 filings — 45,000 shares, $27,654,682 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 7,000 shares @ $600.00 ($4,200,000) in NORTHROP GRUMMAN CORP /DE/, filed 2026-01-07.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NORTHROP GRUMMAN CORP /DE/ (NOC) | Chair, CEO and President, Director | 10 | — | 12 legs · 45,000 sh · $27,654,682 | 25 |
| Merck & Co., Inc. (MRK) | Director | 3 | — | — | 3 |
Form 4 filings — Warden Kathy J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Grant/award (A): 35,910 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 1,853.10 (derivative) @ $118.72 | EDGAR |
| 2026-02-19 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Option exercise (M): 10,760 @ $0 · Tax withholding (F): 4,857 @ $701.12 · Option exercise (M): 10,760 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Option exercise (M): 34,546.16 @ $0 · Tax withholding (F): 15,371 @ $678.83 · Grant/award (A): 28,785.16 (derivative) @ $0 · Grant/award (A): 8,113 (derivative) @ $0 · Option exercise (M): 34,546.16 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Sale (S): 214 @ $705.84 · Sale (S): 2,196 @ $706.65 · Sale (S): 4,695 @ $707.45 · Sale (S): 2,303 @ $708.63 · Sale (S): 5,734 @ $709.49 · Sale (S): 3,552 @ $710.36 · +1 more | EDGAR |
| 2026-01-07 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Sale (S): 7,000 @ $600 · Sale (S): 3,000 @ $615 | EDGAR |
| 2025-06-13 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Sale (S): 3,750 @ $495 · Sale (S): 7,500 @ $505.77 | EDGAR |
| 2025-06-03 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 2,863.09 (derivative) @ $76.84 | EDGAR |
| 2025-03-06 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Sale (S): 3,750 @ $475.65 | EDGAR |
| 2025-02-20 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Option exercise (M): 27,350.27 @ $0 · Tax withholding (F): 12,335 @ $441.36 · Option exercise (M): 11,672 @ $0 · Tax withholding (F): 4,925 @ $441.36 · Grant/award (A): 27,417.27 (derivative) @ $0 · Grant/award (A): 11,752 (derivative) @ $0 · +2 more | EDGAR |
| 2024-06-04 | 4 | Merck & Co., Inc. (MRK) | Grant/award (A): 1,752.43 (derivative) @ $125.54 | EDGAR |
| 2024-02-21 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Option exercise (M): 14,776 @ $0 · Tax withholding (F): 6,664 @ $450.96 · Option exercise (M): 14,776 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | NORTHROP GRUMMAN CORP /DE/ (NOC) | Option exercise (M): 45,832.05 @ $0 · Tax withholding (F): 20,335 @ $446.37 · Grant/award (A): 11,155 (derivative) @ $0 · Grant/award (A): 37,636.05 (derivative) @ $0 · Option exercise (M): 45,832.05 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1559112 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →